Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation

European Journal of Immunology

Volumn 42, Issue 8, 2012, Pages 2142-2151

  Serrano Pertierra, Esther ^a   Cernuda Morollón, Eva ^a   López Larrea, Carlos ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Section of Nephrology   (Spain)

Author keywords

Chemotaxis; Migration; NKG2D; Rho GTPases; WASp

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STROMAL CELL DERIVED FACTOR 1; WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RELEASE; CYTOSKELETON; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL SYNAPSE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

CDC42 GTP-BINDING PROTEIN; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; HUMANS; IMMUNE EVASION; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RAC1 GTP-BINDING PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84864742265     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142070     Document Type: Article

References (47)

1. Lanier, L. L., NK-cell recognition. Ann. Rev. Immmunol. 2005. 23: 225-274.
2. Moretta, L., Biassoni, R., Bottino, C., Mingari, M. C. and Moretta, A., Human NK-cell receptors. Immunol. Today. 2000. 21: 420-422.
3. Vély, F. and Vivier, E., Natural killer cell receptor signaling pathway. Sci. STKE. 2005. 292: cm6.
4. López-Larrea, C., Suárez-Álvarez, B., López-Soto, A., López-Vázquez, A. and González, S., The NKG2D receptor: sensing stressed cells. Trends. Mol. Med. 2008. 14: 179-189.
5. Mistry, A. R. and O'Callaghan, C. A., Regulation of ligands for the activating receptor NKG2D. Immunology 2007. 121: 439-447.
6. Burgess, S. J., Maasho, K., Masilamani, M., Narayanan, S., Borrego, F. and Coligan, J. E., The NKG2D receptor: immunobiology and clinical implications. Immunol. Res. 2008. 40: 18-34.
7. Li, K., Mandai, M., Hamanishi, J., Matsumura, N., Suzuki, A., Yagi, H., Yamaguchi, K. et al., Clinical significance of the NKG2D ligands, MICA/B, and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol. Immunother. 2009. 58: 641-652.
8. Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H. G. and Steinle, A., Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Leukemia. 2003. 102: 1389-1396.
9. Salih, H. R., Rammensee, H. G. and Steinle, A., Down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 2002. 169: 4098-4102.
10. Waldhauer, I. and Steinle, A., Proteolytic release of soluble UL-16 binding protein 2 from tumor cells. Cancer Res. 2006. 66: 2520-2526.
11. Salih, H. R., Holdenrieder, S. and Steinle, A., Soluble NKG2D ligands: prevalence, release and functional impact. Front. Biosci. 2008. 13: 3448-3456.
12. Hedlund, M., Stenqvist, A. C., Nagaeva, O., Kjellberg, L., Wulff, M., Baranov, V. and Mincheva-Nilsson, L., Human placenta expresses and secretes NKG2D ligands via exosomes that downmodulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol. 2009. 183: 340-351.
13. Ashiru, O., Boutet, P., Fernández-Messina, L., Agüera-González, S., Skepper, J. N., Valés-Gómez, M. and Reyburn, H. T., Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA008 that is shed by tumor cells in exosomes. Cancer Res. 2010. 70: 481-489.
14. Clayton, A., Mitchell, J. P., Court, J., Linnane, S., Mason, M. D. and Tabi, Z., Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 2008. 180: 7249-7258.
15. Coudert, J. D. and Held, W., The role of the NKG2D receptor for tumor immunity. Semin. Cancer Biol. 2006. 16: 333-343.
16. Bryceson, Y. T. and Ljunggren, H. G. Tumor cell recognition by the NK-cell activating receptor NKG2D. Eur. J. Immunol. 2008. 38: 2957-2961.
17. Inngjerdingen, M., Damaj, B. and Maghazachi, A. A., Expression and regulation of chemokine receptors in human natural killer cells. Blood. 2001. 97: 367-375.
18. Dustin, M. L., T-cell activation through immunological synapses and kinapses. Immunol. Rev. 2008. 221: 77-89.
19. Cernuda-Morollón, E., Millán, J., Shipman, M., Marelli-Berg, F. M. and Ridley, A. J., Rac activation by the T-cell receptor inhibits T-cell migration. PLoS ONE. 2010. 5: e12393.
20. Culley, F. J., Johnson, M., Evans, J. H., Kumar, S., Crilly, R., Casasbuenas, J., Schnyder, T. et al., Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol. 2009. 7: e1000159.
21. Paschen, A., Sucker, A., Hill, B., Moll, I., Zapatka, M., Nguyen, X. D., Sim, G. C. et al., Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. Clin. Cancer Res. 2009. 15: 5208-5215.
22. Valés-Gómez, M., Chisholm, S. E., Cassady-Cain, R. L., Roda-Navarro, P. and Reyburn, H. T., Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 2008. 68: 1546-1554.
23. Wittmann, T. and Waterman-Storer, C. M., Cell motility: can Rho GTPases and microtubules point the way? J. Cell Sci. 2001. 114: 3795-3803.
24. Ridley, A. J., Rho GTPases and cell migration. J. Cell Sci. 2001. 114: 2713-2722.
25. Peterson, J. R., Bickford, L. C., Morgan, D., Kim, A. S., Ouerfelli, O., Kirschner, M. W. and Rosen, M. K., Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat. Struct. Mol. Biol. 2004. 11: 747-755.
26. Thrasher, A. J., WASp in immune-system organization and function. Nat. Rev. Immunol. 2002. 2: 635-646.
27. Orange, J. S., Ramesh, N., Remold-O'Donnell, E., Sasahara, Y., Koopman, L., Byrne, M., Bonilla, F. A. et al., Wiskott-Aldrich syndrome protein is required for NK-cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc. Natl. Acad. Sci. USA. 2002. 99: 11351-11356.
28. Stabile, H., Carlino, C., Mazza, C., Giliani, S., Morrone, S., Notarangelo, L. D., Notarangelo, L. D. et al., Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta 2 integrin high-affinity state. Blood. 2010. 115: 2818-2826.
29. Masilamani, M., Nguyen, C., Kabat, J., Borrego, F. and Coligan, J. E., CD94/NKG2A inhibits NK-cell activation by disrupting the actin network at the immunological synapse. J. Immunol. 2006. 177: 3590-3596.
30. Zlotnik, A., Chemokines and cancer. Int. J. Cancer. 2006. 119: 2026-2029.
31. Stein, J. V. and Nombela-Arrieta, C., Chemokine control of lymphocyte trafficking: a general overview. Immunology. 2005. 116: 1-12.
32. Vicente-Manzanares, M. and Sánchez-Madrid, F., Role of the cytoskeleton during leukocyte responses. Nature. 2004. 4: 110-120.
33. Sander, E. E., ten Klooster, J. P., van Delft, S., van der Kammen, R. A. and Collard, J. G., Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 1999. 147: 1009-1021.
34. Xu, J., Wang, F., van Keymeulen, A., Herzmark, P., Straight, A., Kelly, K., Takuwa, Y. et al., Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell. 2003. 114: 201-214.
35. Stowers, L., Yelon, D., Berg, L. J. and Chant, J., Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase Cdc42. Proc. Natl. Acad. Sci. USA. 1995. 92: 5027-5031.
36. Etienne-Manneville, E. and Hall, A., Rho GTPases in cell biology. Nature. 2002. 420: 629-635.
37. del Pozo, M. Á., Vicente-Manzanares, M., Tejedor, R., Serrador, J. M. and Sánchez-Madrid, F., Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 1999. 29: 3609-3620.
38. Snapper, S. B., Meelu, P., Nguyen, D., Stockton, B. M., Bozza, P., Alt, F. W., Rosen, F. S. et al., WASp deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J. Leukoc. Biol. 2005. 77: 993-998.
39. Haddad, E., Zugaza, J. L., Louache, F., Debili, N., Crouin, C., Schwarz, K., Fischer, A. et al., The interaction between Cdc42 and WASp is required for SDF-1-induced T-lymphocyte chemotaxis. Blood. 2001. 97: 33-38.
40. Gallego, M. D., de la Fuente, M. A., Anton, I. M., Snapper, S., Fuhlbrigge, R. and Geha, R. S., WIP and WASP play complementary roles in T-cell homing and chemotaxis to SDF-1α. Int. Immunol. 2005. 18: 221-232.
41. Gismondi, A., Cifaldi, L., Mazza, C., Giliani, S., Parolini, S., Morrone, S., Jacobelli, J. et al., Impaired natural and CD16-mediated NK-cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK functional defect. Blood. 2004. 104: 436-443.
42. Orange, J. S., Roy-Ghanta, S., Mace, E. M., Maru, S., Rak, G. D., Sanborn, K. B., Fasth, A. et al., IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK-cell function. J. Clin. Invest. 2011. 121: 1535-1548.
43. Bompard, G. and Caron, E., Regulation of WASP/WAVE proteins: making a long story short. J. Cell Biol. 2004. 166: 957-962.
44. Golub, T. and Caroni, P., PI(4, 5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motitlity. J. Cell Biol. 2005. 169: 151-165.
45. Banerjee, P. P., Pandey, R., Zheng, R., Suhosky, M. M., Monaco-Shawver, L. and Orange, J. S., Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK-cell immunological synapse. J. Exp. Med. 2007. 204: 2305-2320.
46. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M., Tantravahi, R. and Ritz, J., Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 1996. 24: 406-415.
47. Burns, S. O., Killock, D. J., Moulding, D. A., Metelo, J., Nunes, J. Taylor, R. R., Forge, A. et al., A congenital activating mutant of WASp causes altered plasma membrane topography and adhesion under flow in lymphocytes. Blood. 2010. 115: 5355-5365.